Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Pharmacotherapy|September 24, 2022
Evaluating the evidence for sacubitril/valsartan across the continuum of heart failurePreston T Skersick, Darrian Proco, Preetika Sharma-Huynh, et al.
Clinical Transplantation|August 4, 2018
A case-control study of the risk factors for developing aspergillosis following cardiac transplantJennifer C Cook, Abigail Cook, Richard H Tran, et al.
Medical Care|March 21, 2015
Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount ProgramsLei Zhou, Sally C Stearns, Emily M Thudium, et al.
Pharmacotherapy|March 29, 2014
Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need?Craig J Beavers, Khalid A Alburikan, Jo E Rodgers, et al.
Pharmacotherapy|November 22, 2021
Chemotherapy-associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategiesJustin A Veeder, Lauren N Hothem, Amber E Cipriani, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 7, 2011
Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomogramsAbigail E Miller, Deborah Montague, Jo E Rodgers, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 15, 2024
Optimal P2Y<sub>12</sub> inhibitor durations in older men and older women following an acute myocardial infarction: A nationwide cohort study using Medicare dataRyan P Hickson, Anna M Kucharska-Newton, Jo E Rodgers, et al.
Pharmacotherapy|April 5, 2013
Clinical update on the management of atrial fibrillationIlya M Danelich, Brent N Reed, Ian B Hollis, et al.
American Journal of Pharmaceutical Education|July 16, 2020
Maintaining Core Values in Postgraduate Programs During the COVID-19 PandemicAdam M Persky, Kathryn A Fuller, Michael Jarstfer, et al.
The Annals of Pharmacotherapy|February 12, 2024
Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate CancerBrian Lam, Jo E Rodgers, Benyam Muluneh, et al.
Pageof 6